Literature DB >> 3881349

Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide.

J W Zigterman, J E van Dam, H Snippe, F T Rotteveel, M Jansze, J M Willers, J P Kamerling, J F Vliegenthart.   

Abstract

The tetrasaccharide repeating unit of the capsular polysaccharide of Klebsiella serotype 11, K11PS, comprises the following sequence: [----3)-beta-D-GlcpA-(1----3)-alpha-D-Galp-(1----3)-beta-D-Glcp-(1 ----] with a 4,6-O-(1-carboxyethylidene)-alpha-D-galactopyranosyl residue linked to O-4 of the glucuronic acid residue. Octasaccharide (OS) derived from K11PS by bacteriophage phi 11-associated glycanase, was coupled to bovine serum albumin and to keyhole limpet hemocyanin. The immunogenicity of various antigens after intraperitoneal immunization was studied by measuring the levels of circulating antibodies. Injection of BALB/c mice with K11PS resulted in induction of 2-mercaptoethanol-sensitive immunoglobulin M antibodies. The responses observed in BALB/c nu/nu mice and in male (CBA/N X C3H/HeN)F1 mice indicate that K11PS is a thymus-independent type 2 antigen. Immunization of BALB/c mice with either OS-bovine serum albumin or OS-keyhole limpet hemocyanin resulted in the induction of circulating 2-mercaptoethanol-resistant immunoglobulin G antibodies. Results in BALB/c nu/nu mice indicate that the OS-protein conjugates are thymus-dependent antigens. Since the OS-keyhole limpet hemocyanin conjugate induced antibodies in both (CBA/N X C3H/HeN)F1 females and males, we propose to refer to this kind of antigen as a thymus-dependent type 1 antigen, whereas OS-bovine serum albumin, which evoked immunoglobulins in (CBA/N X C3H/HeN)F1 females only, can be referred to as a thymus-dependent type 2 antigen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881349      PMCID: PMC263186          DOI: 10.1128/iai.47.2.421-428.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Deficient production of a thymus-dependent high affinity antibody subset in mice (CBA/N) with an X-linked B lymphocyte defect.

Authors:  R K Gershon; K Kondo
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

2.  Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response.

Authors:  H C Morse; B Prescott; S S Cross; P W Stashak; P J Baker
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

3.  Inhibition of aldobiouronates in the precipitation of pneumococcal type II and III systems.

Authors:  M Heidelberger; N Roy; C P Glaudemans
Journal:  Biochemistry       Date:  1969-12       Impact factor: 3.162

Review 4.  Bacterial endotoxins and host immune responses.

Authors:  D C Morrison; J L Ryan
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

5.  Comparative study of host capsule depolymerases associated with Klebsiella bacteriophages.

Authors:  D Rieger-Hug; S Stirm
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

6.  Bacteriophage-borne enzymes in carbohydrate chemistry. Part I. On the glycanase activity associated with particles of Klebsiella bacteriophage No. 11.

Authors:  H Thurow; H Niemann; S Stirm
Journal:  Carbohydr Res       Date:  1975-05       Impact factor: 2.104

7.  Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.

Authors:  H Snippe; A J van Houte; J E van Dam; M J De Reuver; M Jansze; J M Willers
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Escherichia coli capsule bacteriophages. II. Morphology.

Authors:  S Stirm; E Freund-Mölbert
Journal:  J Virol       Date:  1971-09       Impact factor: 5.103

9.  Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates.

Authors:  E C Beuvery; F van Rossum; J Nagel
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.

Authors:  E C Beuvery; R W van Delft; F Miedema; V Kanhai; J Nagel
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more
  10 in total

1.  Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharide-protein vaccines.

Authors:  G J Zigterman; H Snippe; M Jansze; E B Ernste; M J De Reuver; J M Willers
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

2.  Stimulation of liposome-induced humoral immune responses by non-ionic block polymer surfactants in Xid mice.

Authors:  G J Zigterman; M Jansze; H Snippe; J M Willers
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

3.  Progress towards the development of Klebsiella vaccines.

Authors:  Myeongjin Choi; Sharon M Tennant; Raphael Simon; Alan S Cross
Journal:  Expert Rev Vaccines       Date:  2019-06-28       Impact factor: 5.217

4.  A New Live Auxotrophic Vaccine Induces Cross-Protection against Klebsiella pneumoniae Infections in Mice.

Authors:  Miriam Moscoso; Juan A Vallejo; Maria P Cabral; Patricia García; Víctor Fuentes-Valverde; Eva Gato; Jorge Arca-Suárez; Pablo Aja-Macaya; Germán Bou
Journal:  Vaccines (Basel)       Date:  2022-06-16

5.  Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates.

Authors:  G J Zigterman; K Schotanus; E B Ernste; G J Van Dam; M Jansze; H Snippe; J M Willers
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

6.  Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  L C Paoletti; M R Wessels; F Michon; J DiFabio; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

7.  Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.

Authors:  A F Verheul; A A Versteeg; M J De Reuver; M Jansze; H Snippe
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

8.  Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid.

Authors:  A Fattom; C Lue; S C Szu; J Mestecky; G Schiffman; D Bryla; W F Vann; D Watson; L M Kimzey; J B Robbins
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 9.  The role of vaccines in combatting antimicrobial resistance.

Authors:  Francesca Micoli; Fabio Bagnoli; Rino Rappuoli; Davide Serruto
Journal:  Nat Rev Microbiol       Date:  2021-02-04       Impact factor: 60.633

10.  Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host.

Authors:  Zhehui Peng; Jun Wu; Kangfeng Wang; Xin Li; Peng Sun; Lulu Zhang; Jing Huang; Yan Liu; Xiaoting Hua; Yunsong Yu; Chao Pan; Hengliang Wang; Li Zhu
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.